Curtis Lockshin - Net Worth and Insider Trading

Curtis Lockshin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Curtis Lockshin owns 7 companies in total, including Xenetic Biosciences Inc (XBIO) , Phio Pharmaceuticals Corp (PHIO) , and ChromaDex Corp (CDXC) among others .

Click here to see the complete history of Curtis Lockshin’s form 4 insider trades.

Insider Ownership Summary of Curtis Lockshin

Ticker	Comapny	Transaction Date	Type of Owner
XBIO	Xenetic Biosciences Inc	2017-01-01	Chief Scientific Officer
PHIO	Phio Pharmaceuticals Corp	2013-04-18	director
CDXC	ChromaDex Corp	2011-03-30	director
		2010-02-05	director
		2009-09-25	director
		2007-10-30	director
		2006-07-05	director

Curtis Lockshin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Curtis Lockshin Ownership Network

Ownership Network List of Curtis Lockshin

No Data

Ownership Network Relation of Curtis Lockshin

Curtis Lockshin Owned Company Details

What does Xenetic Biosciences Inc do?

Who are the key executives at Xenetic Biosciences Inc?

Curtis Lockshin is the Chief Scientific Officer of Xenetic Biosciences Inc. Other key executives at Xenetic Biosciences Inc include Chief Financial Officer James F Parslow , 10 percent owner Pharmsynthez Pjsc , and 10 percent owner Synbio Llc .

Xenetic Biosciences Inc (XBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xenetic Biosciences Inc (XBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xenetic Biosciences Inc (XBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xenetic Biosciences Inc (XBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xenetic Biosciences Inc Insider Transactions

No Available Data

What does Phio Pharmaceuticals Corp do?

Who are the key executives at Phio Pharmaceuticals Corp?

Curtis Lockshin is the director of Phio Pharmaceuticals Corp. Other key executives at Phio Pharmaceuticals Corp include Chief Development Officer Gerrit Dispersyn , Chief Development Officer John A Barrett , and director & President and CEO Geert Cauwenbergh .

Phio Pharmaceuticals Corp (PHIO) Insider Trades Summary

Over the past 18 months, Curtis Lockshin made no insider transaction in Phio Pharmaceuticals Corp (PHIO). Other recent insider transactions involving Phio Pharmaceuticals Corp (PHIO) include a net purchase of 13,215 shares made by Robert J Bitterman , and a net purchase of 9,000 shares made by Robert L Ferrara .

In summary, during the past 3 months, insiders sold 0 shares of Phio Pharmaceuticals Corp (PHIO) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Phio Pharmaceuticals Corp (PHIO) were sold and 7,810 shares were bought by its insiders, resulting in a net purchase of 7,810 shares.

Phio Pharmaceuticals Corp (PHIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Phio Pharmaceuticals Corp Insider Transactions

No Available Data

What does ChromaDex Corp do?

Who are the key executives at ChromaDex Corp?

Curtis Lockshin is the director of ChromaDex Corp. Other key executives at ChromaDex Corp include SVP Finance / Interim CFO Brianna Gerber , 10 percent owner Champion River Ventures Ltd , and director & 10 percent owner & Chief Executive Officer Jaksch Frank L Jr .

ChromaDex Corp (CDXC) Insider Trades Summary

Over the past 18 months, Curtis Lockshin made no insider transaction in ChromaDex Corp (CDXC). Other recent insider transactions involving ChromaDex Corp (CDXC) include a net purchase of 3,467,778 shares made by Champion River Ventures Ltd , a net purchase of 7,000 shares made by Robert N Fried , and a net purchase of 7,000 shares made by Steven D Rubin .

In summary, during the past 3 months, insiders sold 0 shares of ChromaDex Corp (CDXC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChromaDex Corp (CDXC) were sold and 3,493,778 shares were bought by its insiders, resulting in a net purchase of 3,493,778 shares.

ChromaDex Corp (CDXC)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChromaDex Corp Insider Transactions

No Available Data

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

Curtis Lockshin is the director of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Therapeutics Inc Insider Transactions

No Available Data

What does Winston Pharmaceuticals Inc do?

Who are the key executives at Winston Pharmaceuticals Inc?

Curtis Lockshin is the director of Winston Pharmaceuticals Inc. Other key executives at Winston Pharmaceuticals Inc include 10 percent owner Frost Phillip Md Et Al , 10 percent owner Frost Gamma Investments Trust , and 10 percent owner Steven Jerry Glauser .

Winston Pharmaceuticals Inc (WPHM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Winston Pharmaceuticals Inc (WPHM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Winston Pharmaceuticals Inc (WPHM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Winston Pharmaceuticals Inc (WPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Winston Pharmaceuticals Inc Insider Transactions

No Available Data

What does BioCardia Inc do?

Who are the key executives at BioCardia Inc?

Curtis Lockshin is the director of BioCardia Inc. Other key executives at BioCardia Inc include 10 percent owner Frost Phillip Md Et Al , 10 percent owner Frost Gamma Investments Trust , and Senior Vice President & Devices Edward M Gillis .

BioCardia Inc (BCDA) Insider Trades Summary

Over the past 18 months, Curtis Lockshin made no insider transaction in BioCardia Inc (BCDA). Other recent insider transactions involving BioCardia Inc (BCDA) include a net purchase of 465,436 shares made by Frost Phillip Md Et Al ,

In summary, during the past 3 months, insiders sold 0 shares of BioCardia Inc (BCDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 129,802 shares of BioCardia Inc (BCDA) were sold and 595,238 shares were bought by its insiders, resulting in a net purchase of 465,436 shares.

BioCardia Inc (BCDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioCardia Inc Insider Transactions

No Available Data

What does Protalix BioTherapeutics Inc do?

Who are the key executives at Protalix BioTherapeutics Inc?

Curtis Lockshin is the director of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .

Protalix BioTherapeutics Inc (PLX) Insider Trades Summary

Over the past 18 months, Curtis Lockshin made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz , and a net purchase of 64,516 shares made by Dror Bashan .

In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.

Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Protalix BioTherapeutics Inc Insider Transactions

No Available Data

Curtis Lockshin Mailing Address

Above is the net worth, insider trading, and ownership report for Curtis Lockshin. You might contact Curtis Lockshin via mailing address: 4400 Biscayne Boulevard, Suite 950, Miami Fl 33137.

Discussions on Curtis Lockshin

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.